Lai Chung-Chih, Shi Zhi-Yuan, Chen Yen-Hsu, Wang Fu-Der
Division of Infectious Diseases, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Division of Infectious Diseases, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan; School of Medicine, National Yang-Ming University, Taipei, Taiwan.
J Microbiol Immunol Infect. 2016 Feb;49(1):74-82. doi: 10.1016/j.jmii.2015.05.011. Epub 2015 Jun 27.
The effects of various antimicrobial stewardship programs (ASPs) on both antibiotic consumption and resistance among different hospitals within the same insurance system have rarely been investigated.
This 6-year retrospective study included three medical centers with similar facilities and infection control measures in Taiwan. These hospitals used different types of ASPs: one had a hospital-wide preauthorization requirement by infectious diseases physicians for all broad-spectrum antibiotics, covering all intensive care units; the second used the same program, but excluded all intensive care units; and the third used postprescription review only. The nonsusceptibility of unduplicated isolates of gram-negative bacilli causing health care-associated infections and consumption of broad-spectrum antibiotics were analyzed.
Overall, the usage of broad-spectrum antibiotics of all classes escalated significantly over time in all three hospitals, but consumption was lowest under the hospital-wide preauthorization program. Under this ASP, despite a 2-fold increase in the total broad-spectrum antibiotic consumption during study period, some declining trends of resistance were found, including ciprofloxacin-resistant Pseudomonas aeruginosa and Acinetobacter baumannii, and carbapenem-resistant P. aeruginosa. By contrast, the other two hospitals with preauthorization program excluding all intensive care units and postprescription review had similar high broad-spectrum antibiotic consumption, comparable growing trends of resistant strains in general, and the correlations of antibiotic consumption and resistance were basically positive. Carbapenem-resistant A. baumannii increased significantly over time in all three hospitals.
This interhospital comparison suggested that hospital-wide preauthorization program is the most effective to reduce key gram-negative bacilli resistance, with the exception of carbapenem-resistant A. baumannii.
同一保险体系内不同医院中,各种抗菌药物管理计划(ASP)对抗生素使用及耐药性的影响鲜有研究。
这项为期6年的回顾性研究纳入了台湾地区设施和感染控制措施相似的三家医疗中心。这些医院采用了不同类型的ASP:一家要求感染科医生对所有广谱抗生素进行全院预授权,涵盖所有重症监护病房;另一家采用相同方案,但不包括所有重症监护病房;第三家仅采用处方后审查。分析了引起医疗保健相关感染的革兰氏阴性杆菌非重复分离株的耐药性以及广谱抗生素的使用情况。
总体而言,所有三家医院各类广谱抗生素的使用随时间均显著增加,但在全院预授权方案下使用量最低。在此ASP下,尽管研究期间广谱抗生素总使用量增加了两倍,但仍发现一些耐药性下降趋势,包括对环丙沙星耐药的铜绿假单胞菌和鲍曼不动杆菌,以及对碳青霉烯类耐药的铜绿假单胞菌。相比之下,另外两家采用不包括所有重症监护病房的预授权方案和处方后审查的医院,广谱抗生素使用量同样较高,总体耐药菌株增长趋势相当,抗生素使用与耐药性的相关性基本呈正相关。所有三家医院中,对碳青霉烯类耐药的鲍曼不动杆菌随时间均显著增加。
这项医院间比较表明,全院预授权方案在降低关键革兰氏阴性杆菌耐药性方面最为有效,但对碳青霉烯类耐药的鲍曼不动杆菌除外。